Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02598661
Title Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Geron Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | POL | NLD | ITA | ISR | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BEL


No variant requirements are available.